Evidence map›Paper›PMID 35860019›Full record

ArticleFrontiers in pharmacology2022

Beneficial Effect of Short-Term Supplementation of High Dose of Vitamin D

Miguel Cervero, Daniel López-Wolf, Guiomar Casado, Maria Novella-Mena, Pablo Ryan-Murua, María Luisa Taboada-Martínez, Sara Rodríguez-Mora, Lorena Vigón, Mayte Coiras, Montserrat Torres

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Effect of vitamin DClinics (Sao Paulo, Brazil) · 2024
    Trial
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Miguel CerveroInternal Medicine Service, Hospital Universitario Severo Ochoa, Leganés, Spain.
Daniel López-WolfInternal Medicine Service, Hospital Universitario Fundación Alcorcón, Alcorcón, Spain.
Guiomar CasadoImmunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Maria Novella-MenaInternal Medicine Service, Hospital Universitario Príncipe de Asturias, Madrid, Spain.
Pablo Ryan-MuruaInternal Medicine Service, Hospital Universitario Infanta Leonor, Madrid, Spain.
María Luisa Taboada-MartínezInternal Medicine Service, Hospital Universitario de Cabueñes, Gijón, Spain.
Sara Rodríguez-MoraImmunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Lorena VigónImmunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Mayte CoirasImmunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Montserrat TorresImmunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is now sufficient evidence to support that vitamin D deficiency may predispose to SARS-CoV-2 infection and increase COVID-19 severity and mortality. It has been suggested that vitamin D

Indexed as

biochemical parametersCOVID-19risk factorsSARS-CoV-2vitamin D3 supplementation

Identifiers

PMID35860019
PMCPMC9289223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.